A detailed history of Proficio Capital Partners LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Proficio Capital Partners LLC holds 3,261 shares of MRNA stock, worth $128,450. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,261
Previous 3,928 16.98%
Holding current value
$128,450
Previous $466,000 53.43%
% of portfolio
0.02%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$63.64 - $125.14 $42,447 - $83,468
-667 Reduced 16.98%
3,261 $217,000
Q2 2024

Jul 25, 2024

BUY
$101.21 - $166.61 $15,991 - $26,324
158 Added 4.19%
3,928 $466,000
Q1 2024

May 02, 2024

BUY
$85.37 - $115.44 $32,099 - $43,405
376 Added 11.08%
3,770 $401,000
Q4 2023

Feb 13, 2024

SELL
$69.51 - $104.43 $208 - $313
-3 Reduced 0.09%
3,394 $337,000
Q3 2023

Oct 18, 2023

BUY
$96.41 - $126.61 $327,504 - $430,094
3,397 New
3,397 $350,000
Q1 2023

Apr 19, 2023

BUY
$135.66 - $197.02 $14.9 Million - $21.7 Million
109,963 New
109,963 $16.9 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $123,804 - $230,113
-979 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $2,935 - $4,790
-13 Reduced 1.31%
979 $249,000
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $23,299 - $50,869
-105 Reduced 9.57%
992 $382,000
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $142,511 - $257,773
1,097 New
1,097 $258,000
Q3 2019

Nov 13, 2019

SELL
$12.26 - $18.07 $821 - $1,210
-67 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$13.7 - $28.34 $917 - $1,898
67 New
67 $1,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.